After stopping the drug, the drug manufacturer said that the Coronavirus vaccine from Oxford may still be ready for X. AstraZeneca’s Chief Executive Officer Pascal Soriot briefed in an offline program. He believes that the development of the vaccine is ‘on track’.
Kovind Vaccine X may be ready
The company halted testing on Wednesday after a British volunteer carrying the vaccine had developed a spinal cord problem. Oxford’s vaccine is one of 9 vaccines to reach the final stage of testing in the world. The World Health Organization has expressed high hopes for AstraZeca. For this, the number of millions of doses has been received from all over the world. Chief Executive Officer Siroat said Volunteer’s illness has been identified and an application is being sent to the Independent Safety Committee for review. Only then will the decision to continue the trial be taken.
AstraZeneca had to stop when the woman fell ill
On the question of stopping the test, he said that it has to be ‘very ordinary’ during such human trials. AstraZeneca vaccine AZD1222 is being tested on 60 thousand volunteers. For this, Volunteer has been included in the US, Jason, UK, South Africa. The Health Secretary has also claimed that the vaccine may not be available until this year. “I think it’s more likely that the vaccine will be ready early next year,” he said.
Can Vitamin D Supplement Calcified Seoul Reduce The Risk Of Death Of Split-19 Patients?
Covid Vaccine: AstraZeneca’s test Wilton-SII after approval from OGI